Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality

Details for Australian Patent Application No. 2001253401 (hide)

Owner AtheroGenics, Inc

Inventors Sirorski, James; Saxena, Uday; Luchoomun, Jayraz; Meng, Charles Q.

Agent Blake Dawson Waldron Patent Services

Pub. Number AU-B-2001253401

PCT Pub. Number WO01/77072

Priority 60196201 11.04.00 US

Filing date 11 April 2001

Wipo publication date 23 October 2001

Acceptance publication date 7 December 2006

International Classifications

A61K 31/7034 (2006.01)

A61K 31/10 (2006.01)

A61K 31/192 (2006.01)

A61K 31/198 (2006.01)

A61K 31/255 (2006.01)

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C07C 323/20 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

G01N 33/92 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving lipids, e.g. cholesterol

Event Publications

7 December 2006 Application Accepted

  Published as AU-B-2001253401

5 April 2007 Standard Patent Sealed

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001253402-SYSTEM AND METHOD FOR MANAGING AND TRACKING CUSTOMER INCENTIVE SECURITIES

2001253400-A method to prevent graft rejection using tgf-beta to induce t suppressor cells